BMP8A Antibody - N-terminal region : FITC (ARP65414_P050-FITC)

Product Specifications

Gene Name

Bone morphogenetic protein 8a

Gene Aliases

OP-2

Gene ID

353500

Swiss Prot

Q7Z5Y6

Accession Number

NP_861525

Host

Rabbit

Reactivity

Human, Mouse, Rat, Cow, Dog, Guinea Pig, Horse, Rabbit, Zebrafish

Immunogen

The immunogen is a synthetic peptide directed towards the N-terminal region of Human BMP8A

Target

BMP8A induces cartilage and bone formation. BMP8A may be the osteoinductive factor responsible for the phenomenon of epithelial osteogenesis. BMP8A plays a role in calcium regulation and bone homeostasis .

Partner Proteins

Dlg4

Clonality

Polyclonal

Conjugation

FITC: Fluorescein Isothiocyanate

Type

Polyclonal Antibody

Applications

Purification

Affinity Purified

Sample Type

BMP8A is strongly supported by BioGPS gene expression data to be expressed in HEK293T

Concentration

0.5 mg/ml

Homology

Cow: 86%; Dog: 86%; Guinea Pig: 93%; Horse: 80%; Human: 100%; Mouse: 93%; Rabbit: 93%; Rat: 93%; Zebrafish: 80%

Format

Liquid. Purified antibody supplied in 1x PBS buffer.

Reconstitution

All conjugated antibodies should be stored in light-protected vials or covered with a light protecting material (i.e. aluminum foil) . Conjugated antibodies are stable for at least 12 months at 4C. If longer storage is desired (24 months), conjugates may be diluted with up to 50% glycerol and stored at -20C to -80C. Freezing and thawing conjugated antibodies will compromise enzyme activity as well as antibody binding.